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Arsenic is widely distributed in nature in the form of
either metalloids or chemical compounds, which cause
a variety of pathologic conditions including cutaneous
and visceral malignancies. Recently, reactive oxygen
species have been hypothesized to be one of the causes
of arsenic-induced carcinogenesis. 8-Hydroxy-29-
deoxyguanosine is one of the major reactive oxygen
species-induced DNA base-modified products that is
widely accepted as a sensitive marker of oxidative
DNA damage. We studied the presence of 8-hydroxy-
29-deoxyguanosine by immunohistochemistry using
N45.1 monoclonal antibody in 28 cases of arsenic-
related skin neoplasms and arsenic keratosis as well as
in 11 cases of arsenic-unrelated Bowen’s diseases. The
Arsenic is widely found in nature and is distributedthroughout the environment by water. It has beenused in various ways: as pesticides, in silicon watertechnology such as computer microchips, chemicalweapons, and traditional forms of medicine. Epidemi-
ologic studies have revealed that inorganic arsenic is carcinogenic
for human organs, including the lung, liver, skin, bladder, and
kidney (Yeh, 1973; Blot and Fraumeni, 1975; IARC, 1980;
Schwartz, 1997). Arsenic-induced skin cancers or skin diseases in
patients from some endemic areas in Taiwan, Thailand, and Japan
(Chen et al, 1992; Imamura and Odaka, 1962) are quite common.
Its carcinogenic mechanism, however, so far remains unclear.
An in vitro study has shown that arsenic induces chromosome
aberrations and DNA-protein cross-links (IARC, 1980). Reactive
oxygen species (ROS) produced by dimethylarsenic acid, one of
the major metabolites of inorganic arsenics, were suggested to be
involved in the generation of DNA damage (Yamanaka et al, 1989).
Recently, Wanibuchi et al (1997) found that dimethylarsenic acid
has the potential to promote rat liver carcinogenesis, possibly via a
mechanism involving stimulation of cell proliferation and DNA
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frequency of 8-hydroxy-29-deoxyguanosine positive
cases was significantly higher in arsenic-related skin
neoplasms (22 of 28; 78%) than in arsenic-unrelated
Bowen’s disease (one of 11; 9%) (p < 0.001 by c2 test).
8-Hydroxy-29-deoxyguanosine was also detected in
normal tissue adjacent to the arsenic-related Bowen’s
disease lesions. Furthermore, arsenic was detected by
neutron activation analysis in the deparaffined skin
tumor samples of arsenic-related disease (four of five;
80%), whereas arsenic was not detected in control
samples. Our results strongly suggest the involvement
of reactive oxygen species in arsenic-induced human
skin cancer. Key word: neutron activation analysis. J Invest
Dermatol 113:26–31, 1999
damage caused by ROS. This prompted us to investigate the
involvement of ROS in arsenic-induced human skin cancers.
8-Hydroxy-29-deoxyguanosine (8-OHdG) is generated by
hydroxyl radical (Kasai and Nishimura, 1984), singlet oxygen (Floyd
et al, 1989; Devasagayam et al, 1991), or direct electron transfer,
which does not involve the participation of any ROS (Kasai et al,
1992). 8-OHdG is considered to be one of the main oxidative
base damage to DNA, and may cause mutation (G:C to T:A) at
DNA replication (Shibutani et al, 1991). Currently, 8-OHdG is
widely accepted as a sensitive marker of oxidative DNA damage
and oxidative stress. In the present study, we examined whether
neoplastic and precancerous skin lesions of arsenic-related indi-
viduals are oxidatively stressed using 8-OHdG as a marker. As
UVB, especially in vivo (Hattori et al, 1997) and mainly UVA and
visible light in the presence of photosensitizer (Kvam and Tyrrell,
1997; Rosen et al, 1997) participate in ROS formation, all skin
materials were obtained from non-sun-exposed or less sun-exposed
areas in order to minimize the effect of sun exposure upon 8-
OHdG generation.
8-OHdG measurement by high-performance liquid chromato-
graphy using an electrochemical detector has been a widely accepted
method for such an investigation. A large amount of DNA,
however, is required for high-performance liquid chromatography–
electrochemical detection analysis. As we could obtain only a small
amount of paraffin-embedded blocks, we chose to carry out
semiquantitative immunohistochemical measurement of 8-OHdG
by determining the signal intensity using monoclonal antibody
against 8-OHdG (N45.1). This method has been shown to correlate
well with 8-OHdG levels by high-performance liquid chromato-
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Table I. 8-OHdG detection in arsenic-related skin tumors
Characteristics of histopathology
Individual 8-OHdGb
Cases Age Sex Diagnosisa Site Mitosis keratinization Clumping cell detection
Non-exposed area
1 68 Md BD abdomen 1 – – 11
2 Fc BD thigh 1 – – 11
3 60 Fe BD back 1 – – –
4 26 Me BD penis 11 – – 1
5 59 Fd BD abdomen 11 – 1 11
6 67 Md BD abdomen 1 – 1 11
7 63 Mc BD scrotum 1 1 – –
8 53 Fe BD thigh 1 1 – 11
9 74 Md BD back 11 1 1 11
10 70 Fd BD back 11 11 1 11
11 83 Fc BD thigh 11 11 11 11
12 58 Md BC abdomen 1 – 1 1
13 72 Md BC abdomen 1 1 – 1
14 Mc BC scrotum 1 1 – 1
15 79 Md BC back 1 1 – 11
16 60 Me BC penis 11 11 – –
17 76 Me BC back 11 111 1 –
Less-exposed area
18 63 Mc AK palm – – – –
19 Fc AK palm – – – 11
20 Mc AK foot 1 – – 1
21 60 Mc AK dorsal hand 1 – – 11
22 60 Mc AK knee 1 – – 11
23 61 Me BD chest 1 – – 1
24 53 Md BD chest 1 – 1 –
25 83 Fc BD palm 1 1 1 11
26 87 Me BD chest 1 1 1 11
27 75 Me BD chest 1 1 1 11
28 72 Md BD chest 1 11 1 11
aBD, Bowen’s disease; BC, Bowen’s carcinoma; AK, arsenic keratosis.
bIntensities of 8-OHdG staining were grouped into three grades (–, 1, 11) according to the 8-OHdG index determination. See Materials and Methods for detail.
cSamples from Japan.
dSamples from Taiwan.
eSamples from Thailand.
graphy over the same samples (Toyokuni et al, 1997). We found
that the frequency of 8-OHdG positive tumors is significantly
higher in arsenic-induced epidermal neoplasms than in the arsenic-
unrelated epidermal neoplasms.
Furthermore, we detected arsenic in some of the available tumor
sections using instrumental neutron activation analysis (INAA) in
view of its high sensitivity for the detection of arsenic (Molokhia
and Portnoy, 1969). Possible involvement of ROS in arsenic-
induced carcinogenesis will be discussed.
MATERIALS AND METHODS
Bowen’s disease and arsenic keratosis Samples of arsenic keratosis,
arsenic-induced Bowen’s disease and arsenic-induced Bowen’s carcinoma
arising in non-sun-exposed or less sun-exposed areas were obtained from
28 individuals (age 26–83) from either Taiwan, Thailand, or Japan living
in areas where chronic arsenicism was endemic (Table I). These patients
revealed clinical features characteristic of arsenicism such as cutaneous
melanosis, keratosis of palms and soles (arsenic keratosis) and multiple
Bowen’s disease and internal malignancy. Clinical features of the Japanese
patients were reported in detail previously (Imamura and Odaka, 1962;
Miki et al, 1982). As control tumor samples, arsenic-unrelated Bowen’s
disease and Bowen’s carcinoma of non sun-exposed areas were obtained
from 11 Japanese individuals. Bowen’s disease is defined as ‘‘a persistent,
progressive, nonelevated, red scaly or crusted plaque which is due to an
intraepidermal carcinoma and is potentially malignant’’ (Mackie, 1992),
and we defined Bowen’s carcinoma as invasive squamous carcinoma
developing from a Bowen’s disease.
Immunohistochemistry Skin specimens were fixed in 10% neutral
formalin, then embedded in paraffin, sliced at 3.5 µm, mounted on glass
slides coated with poly L-lysine, and subjected to either hematoxylin/eosin
or immunohistochemical staining using ABC method (Hsu et al, 1981).
Sections were treated with microwave in 10 mM citrate buffer pH 6.0
with 0.1% polyoxyethylene sorbitan monolaurate (Wako, Osaka, Japan)
for 5 min three times for antigen retrieval. Specimens were then incubated
with normal rabbit serum (Dako, Kyoto, Japan; diluted to 1:75) for 30 min,
then incubated with N45.1 monoclonal antibody (2.5 µg per ml) specific
for 8-OHdG (Toyokuni et al, 1997) overnight at 4°C followed by
incubation with biotin-labeled rabbit anti-mouse IgG serum (Dako; Diluted
1:300) for 50 min and finally with avidin–biotin alkaline phosphatase
complex (Vector Laboratories, Burlingame, CA; diluted 1:100) for 40 min.
Substrate for alkaline phosphatase was obtained from Vector.
Adsorption test To confirm the specificity of immunostaining of ROS-
specific products, adsorption tests were performed by adding free antigens,
200 and 500 µM 8-OHdG (final concentration; Wako) on specimens
during the incubation period of primary antibody. Serial sections were
stained with the same procedures with or without free antigens and signal
intensities were compared with each other.
Quantitation of immunohistochemical data The quantitation was
carried out as described previously (Toyokuni et al, 1997). The following
equation was used for the quantitation of immunohistochemical data:
8-OHdG index 5 Σ[(A – threshold) 3 area (pixel)]/total cell number
A . threshold
where A is the staining density indicated by a number on the gray scale.
Specimens stained with hematoxylin and eosin were used for total cell
calculation. Three color images of 35 mm slides for each 8-OHdG
immunohistochemistry specimen were obtained as PICT files with a slide
scanner (Polascan 35: Polaroid, Tokyo, Japan) and the brightness and
contrast of each image file were enhanced by Adobe Photoshop version
3.0 followed by an analysis using NIH image freeware (version 1.59).
Average 8-OHdG index of three to five experiments for each specimen
was obtained. Grade of 8-OHdG detection was expressed as (–, 1, 11)
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Figure 1. 8-OHdG immunostaining in arsenic related skin tumors. Representative 8-OHdG staining of 11, 1, and – are shown in (d), (e), and
(f), respectively. (a) Hematoxylin and eosin staining of arsenic-related Bowen’s disease (case 9 in Table I). Acanthosis and atypical cells with hyperchromatic
nuclei and mitotic figures are observed. (b) Hematoxylin and eosin staining of arsenic-related Bowen’s disease (case 4 in Table I). Acanthosis, papillomatosis,
parakeratotic layer are prominent. (c) Hematoxylin and eosin staining of arsenic-unrelated Bowen’s disease (case 4 in Table II). Acanthosis, papillomatosis,
thick hyperkeratotic and parakeratotic layer, and horn pearls are prominent. Mitotic cells are observed. (d–f) 8-OHdG immunostaining of using monoclonal
antibody specific to 8-OHdG (N45.1) in the same samples as (a–c), respectively. 8-OHdG was detected in the nuclei of epidermal cells. Grade of 8-
OHdG index was 11, 1, –, respectively (Table I). Scale bar: 100 µm. (g) Adsorption test: Specimens of case 9 in Table I was stained exactly the same
as (d) except that adding 200 µM 8-OHdG to specimens during the incubation period of primary antibody. N45.1 was neutralized by the excess free
antigen and 8-OHdG in the specimen was not detected whereas 8-OHdG was detected in the absence of excess free antigen as shown in (d).
Table II. 8-OHdG detection in arsenic-unrelated skin tumors
Characteristics of histopathology
Mitosis Individual Clumping cell 8-OHdGb
Cases Age Sex Diagnosisa Site keratinization detection
1 71 M BD back 1 – – –
2 52 M BD plantar 1 – – –
3 82 M BD hip 1 1 – –
4 74 F BD abdomen 1 1 1 –
5 61 F BD hip 1 1 1 –
6 82 F BD hip 1 1 1 –
7 68 M BD abdomen 1 1 1 –
8 59 F BD back 1 1 1 1
9 44 M BD back 111 1 1 –
10 73 M BD hip 111 11 1 –
11 88 M BC scrotum 1 1 – –
aBD, Bowen’s disease; BC, Bowen’s carcinoma.
bIntensities of 8OHdG staining were grouped into three grades (–, 1, 11) according to the 8-OHdG index determination. See Materials and Methods for detail.
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Figure 2. 8-OHdG staining of arsenic keratosis (case 22,
hematoxylin–eosin staining). (a) Thick compact parakeratotic
hyperkeratosis is overlying a mild keratotic dysplasia. Mitosis or atypical
cells are not observed. (b) 8-OHdG staining of the same samples as (a). 8-
OHdG is also detected in the nuclei of epidermal cells. Scale bar: 100 µm.
by the 8-OHdG index number (–, 0–10; 1, 11–100; 11, .100),
respectively.
Detection of arsenic by INAA In tumor samples which we could
obtain an ample amount, the skin specimens were de-paraffinized by
xylene and ethanol, then sealed in a polyethylene bag after their dry weight
was measured. The specimens in the polyethylene bag were irradiated for
1 h in a pneumatic tube (Pn-2) of KUR (Kyoto University Reactor), with
a thermal neutron flux of 2.8 3 1013 n per cm2 per s to convert 75As to
76As. We measured γ-rays derived from 76As at 559.1 keV 4–5 d after
irradiation by germanium semiconductor detector (efficiency: 18%, peak
to compton: 51/1, total active volume: 90 ml) (EG & G Ortec). Geometry
and counting efficiency were determined before measurement by the
standard elements. In practical measurements, a known amount of the
standard solution was dropped onto a Millipore filter, HAWP04700 (Nihon
Millipore K.K., Tokyo), irradiated, and then used as a flux monitor. The
concentration of the element in the samples was calculated from the
radioactivity in reference to the standard and expressed in micrograms per
g of dry weight (ppm).
RESULTS
Detection of 8-OHdG in arsenic-related and arsenic-unre-
lated skin neoplasms Grade of 8-OHdG staining was expressed
as –, 1, and 11 according to the 8-OHdG index as described in
Materials and Methods. Figure 1(d–f) shows representative staining
of 11, 1, and –, respectively. Thirteen of 17 cases of arsenic-
related epidermal neoplasms of non-sun-exposed area and nine of
11 cases of arsenic-related epidermal neoplasms of less sun-exposed
area were positively stained by monoclonal antibody N45.1 (Fig 1,
Table I). On the contrary, only one of 11 samples of the arsenic-
Figure 3. Detection of 76As in the arsenic related skin tumors by
INAA. (a) 76As is detected from deparaffined samples of arsenic related
Bowen’s disease at the 559.1 keV. (b) 76As is not detected from de-
paraffinized samples of the arsenic unrelated Bowen’s disease.
Table III. Arsenic detection by INAA in skin tumors
Case no. 76As (ppm)
Samples from arsenic-related skin tumorsa
18 0
21 61.8
23 17.1
25 2.72
28 5.71
Samples from arsenic-unrelated tumorsb
1 0
3 0
6 0
aCase numbers correspond to those of Table I.
bCase numbers correspond to those of Table II.
unrelated Bowen’s disease were stained by this monoclonal antibody
(p , 0.001 by χ2 test) (Table II). Clinicopathologic data of the
tumor, and the intensity of 8-OHdG staining (8-OHdG index) are
summarized in the Tables I and II.
In order to confirm the specificity of immunostaining of N45.1,
monoclonal antibody against 8-OHdG, adsorption tests were per-
formed by adding 200 and 500 µM 8-OHdG along with primary
antibody on glass slides. As shown in Fig 1(g) staining color has
disappeared when 8-OHdG was added during the incubation
period of primary antibody.
In the positively stained samples, there was little heterogeneity
in the staining pattern among the areas and almost all the cells
were stained in a section. Moreover, in some samples 8-OHdG
could also be detected in the nontumorous surrounding area of the
epidermal cells or preneoplastic lesions (Fig 2). There was no
correlation between the grade of malignancy (e.g., the number of
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mitotic cells) and the 8-OHdG signal intensity (Table I). Further-
more, 8-OHdG was detected in the arsenic keratosis in the similar
intensity and frequency to those of arsenic-related Bowen’s disease
(Figs 1 and 2, Table I). There was no correlation between the
source of the tumor and signal intensity of 8-OHdG staining. In
control samples, only 9% (one of 11) were positively stained with
monoclonal antibody N45.1 (Table II).
Detection of arsenic in lesions by INAA In arsenic-related
Bowen’s disease, arsenic was detected in four of five cases from
de-paraffinized sample sections(Fig 3 and Table III). In contrast,
in arsenic-unrelated Bowen’s diseases, no arsenic was detected in
three of three cases (Table III).
DISCUSSION
In the present study, we found significantly higher levels of 8-
OHdG in the epidermal nuclei of arsenic-related Bowen’s disease,
Bowen’s carcinoma and arsenic keratosis compared with non-
arsenic-related Bowen’s disease and Bowen’s carcinoma (Table I)
(p , 0.001). Though experimental animal models of arsenic-
induced cancer have not been successfully developed (IARC,
1980), there are several findings which suggest a relationship
between ROS and arsenic. Dimethylarsenic acid was shown to
induce DNA damage via formation of O–•2 and dimethylarsenic-
peroxyl radical (Yamanaka et al, 1989, 1990). Recently a significant
increase in formation of 8-OHdG in the livers of rats after
administration of dimethylarsenic acid was reported (Wanibuchi
et al, 1997). Our observation supports their results that 8-OHdG
is generated by arsenic incorporation and suggests the involvement
of ROS in the arsenic-induced human skin carcinogenesis as well.
There are several lines of evidence to suggest the involvement
of oxidative stress in carcinogenesis. Oxidative stress can be involved
in either initiation, promotion, or progression (Guyton and Kensler,
1993; Kaikobad et al, 1997). 8-OHdG is usually detected in target
organs in high levels in experimental animal models of ROS-
induced carcinogenesis (Toyokuni et al, 1994). It was reported that
there was an increase in 8-OHdG level in the urine of cancer
patients (breast, lung, colon, malignant lymphoma, malignant
teratoma) as compared with healthy individuals (Tagesson et al,
1995). The G:C to T:A transversions, which can be induced by
the presence of 8-OHdG at DNA replication, is found in the RAS
gene and p53 gene in human skin cancers of sun-exposed areas
(Pierceall et al, 1991; Basset-Seguin et al, 1994), and UV-induced
mice skin cancer (Nishigori et al, 1994) as well as transitions at
dipyrimidine sites, signature of pyrimidine dimer presence. These
imply 8-OHdG as one of the causes of solar radiation carcinogenesis.
Increased levels of 8-OHdG in lymphoblasts from Fanconi’s anemia,
a cancer-prone disease, was also reported (Takeuchi and Morimoto,
1993). ROS induced by arsenic may work as a promoter for cells
which have already been initiated by other carcinogens as suggested
by Wanibuchi et al (1997). Persistent oxidative stress in cancer
(Toyokuni et al, 1995) may also cause activation of transcription
factors and protooncogenes such as c-fos and c-jun (Crawford et al,
1988) as well as genetic instability. Such a stress may also contribute
toward maintaining their malignant characteristics of arsenic-related
neoplasms.
The destiny of arsenic incorporated into the human body has
not yet been clarified. Arsenic circulating in the blood binds to
proteins by formation of a covalent complex with sulfhydryl groups
of the amino acid. Cysteine in keratin is one of the major sites for
accumulation of arsenic (Hindmarsh and McCurdy, 1986). To
clarify more directly whether ROS formation is caused by arsenic,
we examined arsenic in the lesions using INAA and revealed that
at least in some specimens, arsenic remains in the skin for many
years after ingestion. Miki et al (1982) reported that neutron
activation analysis of hair showed slightly higher arsenic values in
patients with arsenic-induced Bowen’s disease than normal controls.
Imamura and Odaka (1962) also detected arsenic in significantly
higher amounts in two lesions from arsenic-related Bowen’s disease
than their adjacent nontumorous tissues 20 y after the apparent
arsenic exposure.
Although we could not obtain the specimens for arsenic detection
from nontumorous adjacent tissue in patients with arsenic-related
Bowen’s disease, 8-OHdG was detected not only in the tumor
tissue but also in adjacent normal tissue in some cases where normal
adjacent tissue was available for examination. 8-OHdG was detected
in arsenic-related Bowen’s disease and Bowen’s carcinoma as well
as in arsenic keratosis, which is generally considered to be a
precancerous status. There was no correlation between the grade
of malignancy and formation of 8-OHdG. Recently, the importance
of the glutathione S-transferase supergene family, ROS detoxifying
enzyme, is shown for the susceptibility of the individuals to various
cancers including nonmelanoma skin cancer (Lear et al, 1997).
Arsenic might inactivate these ROS detoxifying enzymes, or
individuals whose ROS detoxifying enzyme activity is low, might
accumulate high levels of ROS leading to arsenic-induced neo-
plasm. Our observations imply that arsenic remaining in the skin
could contribute to the increased levels of oxidative stress for many
years which could be one of the mechanisms of arsenic-induced
carcinogenesis.
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